Cardiac Disease Prevalence Fuels Growth In The Peripheral Arterial Disease Market Driver: A Major Catalyst in the Evolution of the Peripheral Arterial Disease Market in 2025

"How Are the key drivers contributing to the expansion of the peripheral arterial disease market?
The proliferation of heart diseases is a significant factor propelling the advancement of the peripheral arterial disease market. Cardiac disease, a common heart ailment that affects the primary arteries that fuel the heart muscle, has been on the rise. Treatment for peripheral arterial disease can enhance the life of cardiac patients by improving blood flow, reducing cardiovascular risk, alleviating symptoms, and boosting the quality of life. For example, reports from The Australian Bureau of Statistics (ABS), a government agency based in Australia, disclosed that around 1.3 million people, or 5.2% of the population, were living with heart, stroke, and vascular diseases in December 2023. Furthermore, in April 2022, the American College of Cardiology, an American non-profit medical body, foresaw a 30.7% rise in the risk factors for ischemic heart disease, reaching 29 million by 2025. Consequently, the accelerating prevalence of heart diseases fuels the growth of the peripheral arterial disease market. Peripheral Arterial Disease Market Driver: The Escalating Incidence of Diabetes Is Predicted To Boost The Peripheral Arterial Diseases Market

Get Your Peripheral Arterial Disease Market Report Here:
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

What growth opportunities are expected to drive the peripheral arterial disease market's CAGR through 2034?
In recent years, the market size for peripheral arterial disease has seen substantial growth. Projected growth shows an increase from $4.36 billion in 2024 to $4.76 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%. The historic period growth can be credited to the innovation of medical devices, the introduction of gene therapy and regenerative medicine, pharmacogenomics, digital health, and remote patient monitoring.

In the coming years, the market size of peripheral arterial disease is anticipated to witness robust growth. It is projected to escalate to $6.62 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. The projected growth in the forecast period can be linked to factors such as interdisciplinary care teams, minimally invasive interventions, and prescriptions related to lifestyle and exercise. The forecast period is expected to see major trends including vascular tele-rehabilitation, multimodal pain management, advancements in wound care, and public health campaigns.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

What are the emerging trends shaping the future of the peripheral arterial disease market?
Leading firms in the peripheral arterial disease market are concentrating their efforts on the creation of cutting-edge medical devices such as the intravascular lithotripsy (IVL) catheter. These devices aim to increase the efficiency of treatment, enhance patient outcomes and shorten recovery periods for those battling vascular conditions. The IVL catheter is a medical tool used in the management of calcified arterial obstructions; it exerts controlled shockwaves to dismantle the calcium, boosting blood circulation and increasing the flexibility of vessels during procedures like angioplasty. For example, in September 2024, Shockwave Medical, Inc., a medical technology organization based in the U.S., launched the Shockwave E8 peripheral IVL catheter. This device is specifically designed to handle peripheral arterial disease by initiating targeted intravascular lithotripsy, which employ sonic waves to disintegrate calcium deposits in arterial walls. This inventive method aids in restoring blood flow while minimizing tissue damage. Additionally, the catheter's advanced structure facilitates smoother navigation through intricate vascular structures, rendering it apt for a diverse patient population.

Which growth-oriented segments of the peripheral arterial disease market are leading the industry's development?
The peripheral arterial disease market covered in this report is segmented -

1) By Treatment Type: Devices, Catheters, Drugs, Other Types
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By End User: Hospitals, Specialty Clinics, Others End-Users

Subsegments:
1) By Devices: Stents, Balloons, Atherectomy Devices
2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires
3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators
4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12999

What regions are leading the charge in the peripheral arterial disease market?
North America was the largest region in the peripheral artery disease market in 2024. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What companies are at the forefront of innovation in the peripheral arterial disease market?
Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=12999&type=smp

What Is Covered In The Peripheral Arterial Disease Global Market Report?

•Market Size Forecast: Examine the peripheral arterial disease market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the peripheral arterial disease market for a structured understanding.
•Key Players Overview: Analyze major players in the peripheral arterial disease market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the peripheral arterial disease market.
•Segment Contributions: Evaluate how different segments drive overall growth in the peripheral arterial disease market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the peripheral arterial disease market.
•Industry Challenges: Identify potential risks and obstacles affecting the peripheral arterial disease market.
•Competitive Landscape: Review strategic developments in the peripheral arterial disease market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.